The FDA said the burst balloons resulted in “significant difficulty retrieving the valve into the catheter and withdrawing the system from the patient.”
The burst balloon may result in vascular injury, bleeding or the need for surgery.
Edward Lifesciences, based in Irvine, Calif., previously issued a safety notice about the delivery system to physicians on July 9. After the notice, Health Canada issued a medical device recall. Now the FDA has followed suit.
The devices will still be for sale after the devicemaker places additional warnings and instructions on the label. The devicemaker issued recommendations and instructions for physicians, including inflating the balloon slowly and actions to take if a burst balloon is suspected.
The delivery system is used to implant the Edwards Lifesciences transcatheter heart valve into a patient with aortic valve stenosis, a narrowing of the heart’s aortic valve that restricts blood flow.
Class 1 recalls, the most serious, are for products the FDA says could cause serious health problems or death.
More articles on supply chain:
VA, Defense Department to partner on supply-ordering to cut waste, fraud
How US-China trade tensions are affecting the medical device industry
AmerisourceBergen to close California distribution center, cut 100 jobs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.